CULLINAN THERAPEUTICS, INC. (CGEM)
Clinical trial NCT04036682 updates: 1. completion date: 2026-03-31 → 2028-03-31 2. primary completion date: 2026-01-31 → 2025-10-13 3. collaborators added: Taiho Oncology, Inc.
Clinical trial NCT04036682 updates: 1. completion date: 2026-03-31 → 2028-03-31 2. primary completion date: 2026-01-31 → 2025-10-13 3. collaborators added: Taiho Oncology, Inc.
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical